EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis

Rong Liu, Min Zhu, Jiaojiao Chen, Junwei Gai, Jing Huang, Yingqun Zhou, Yakun Wan, Chuantao Tu

International Journal of Nanomedicine · 2023

DOI: 10.2147/ijn.s428430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Rong Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, People's Republic of China. Hauptthemen laut MEDLINE: Connective Tissue Growth Factor, Liver Cirrhosis, Single-Domain Antibodies, Antifibrotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Connective Tissue Growth FactorLiver CirrhosisSingle-Domain AntibodiesAntifibrotic AgentsHumansHepatic Stellate CellsTransforming Growth Factor beta1Cell ProliferationCell LineApoptosisCell MovementAnimalsCamelusSmad2 Protein

Stichwörter der Autor:innen

connective tissue growth factorhepatic stellate cellsliver fibrosisnanobody

Substanzen

Connective Tissue Growth FactorCCN2 protein, humanSingle-Domain AntibodiesTransforming Growth Factor beta1Antifibrotic AgentsTGFB1 protein, humanSmad2 Protein

Autor:innen und Institutionen

  • Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, People's Republic of China.
  • Shanghai Novamab Biopharmaceuticals Co., Ltd, Shanghai, 201318, People's Republic of China.
  • Department of Gastroenterology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, Shanghai, 200434, People's Republic of China.
  • Department of Gastroenterology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, People's Republic of China.

Zitieren

APA

Liu, R., Zhu, M., Chen, J., Gai, J., Huang, J., Zhou, Y., Wan, Y., & Tu, C. (2023). Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s428430

Vancouver

Liu R, Zhu M, Chen J, Gai J, Huang J, Zhou Y, et al. Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s428430

BibTeX
@article{Liu2023,
  author = {Liu, Rong and Zhu, Min and Chen, Jiaojiao and Gai, Junwei and Huang, Jing and Zhou, Yingqun and Wan, Yakun and Tu, Chuantao},
  title = {Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis},
  journal = {International Journal of Nanomedicine},
  year = {2023},
  doi = {10.2147/ijn.s428430}
}
Kostenlos starten →